PROKIDNEY CORP.
For the period ended May 15, 2026. Filed May 15, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
May 15, 2026 · Filed May 15, 2026
Use the contents to explore the available documents and sections.
PROK$1.14+7.0%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · (in thousands, except for share data)
(in thousands, except for share data)
| March 31, 2026 | December 31, 2025 | |
|---|---|---|
| (Unaudited) | ||
| Assets | ||
| Cash and cash equivalents | $101,895 | $108,537 |
| Marketable securities | 123,049 | 161,480 |
| Interest receivable | 1,032 | 1,127 |
| Prepaid assets | 3,083 | 2,808 |
| Prepaid clinical | 4,049 | 3,923 |
| Other current assets | 1,794 | 2,804 |
| Total current assets | 234,902 | 280,679 |
| Fixed assets, net | 54,441 | 51,231 |
| Right of use assets, net | 3,441 | 3,664 |
| Total assets | $292,784 | $335,574 |
| Liabilities and Stockholders' Deficit | ||
| Accounts payable | $2,592 | $940 |
| Lease liabilities | 1,108 | 1,071 |
| Accrued expenses and other | 22,231 | 28,731 |
| Income taxes payable | – | – |
| Total current liabilities | 25,931 | 30,742 |
| Income tax payable, net of current portion | 1,074 | 1,074 |
| Lease liabilities, net of current portion | 2,675 | 2,965 |
| Total liabilities | 29,680 | 34,781 |
| Commitments and contingencies | ||
| Redeemable noncontrolling interest | 1,286,887 | 1,311,990 |
| Stockholders’ deficit | ||
| Class A common stock, $0.0001 par value; 700,000,000 shares authorized as of March 31, 2026 and December 31, 2025; 141,980,643 and 141,807,277 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 14 | 14 |
| Class B common stock, $0.0001 par value; 500,000,000 shares authorized; 159,973,334 and 159,262,779 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively | 16 | 16 |
| Additional paid-in capital | 266,112 | 258,552 |
| Accumulated other comprehensive (loss) gain | (53) | 56 |
| Accumulated deficit | (1,289,872) | (1,269,835) |
| Total stockholders' deficit | (1,023,783) | (1,011,197) |
| Total liabilities and stockholders' deficit | $292,784 | $335,574 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.